{"product_id":"cber-director-response-bluebird-bio-dispute-lyfgenia-bla-125788","title":"CBER Director Response – Bluebird Bio Dispute (Lyfgenia, BLA #125788)","description":"\u003cb\u003eRequest Contents:\u003c\/b\u003e CBER Director Peter Marks' response to Bluebird Bio’s formal dispute resolution request related to the denial of a rare pediatric disease priority review voucher for Lyfgenia (BLA #125788)","brand":"FDA","offers":[{"title":"Default Title","offer_id":50791084687524,"sku":"FDAFT297","price":89.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/foiadocs.com\/products\/cber-director-response-bluebird-bio-dispute-lyfgenia-bla-125788","provider":"FOIA Document Source","version":"1.0","type":"link"}